Transcription factor FOXF2 promotes the development and progression of pancreatic cancer by targeting MSI2
Oncology Reports · 2024
DOI: 10.3892/or.2024.8752 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology Reports, 2024. Verfasst von Bang-Hua Zhong und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Surgery, The First Hospital of China Medical University, Shenyang, Liaoning 110001, P.R. China. Hauptthemen laut MEDLINE: Cell Proliferation, Forkhead Transcription Factors, Gene Expression Regulation, Neoplastic, Pancreatic Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastrointestinal Surgery, The First Hospital of China Medical University, Shenyang, Liaoning 110001, P.R. China.
Zitieren
APA
Zhong, B. H., Ma, Y. T., Sun, J., Tang, J. T., & Dong, M. (2024). Transcription factor FOXF2 promotes the development and progression of pancreatic cancer by targeting MSI2. Oncology Reports. https://doi.org/10.3892/or.2024.8752
Vancouver
Zhong BH, Ma YT, Sun J, Tang JT, Dong M. Transcription factor FOXF2 promotes the development and progression of pancreatic cancer by targeting MSI2. Oncology Reports. 2024. doi:10.3892/or.2024.8752
BibTeX
@article{Zhong2024,
author = {Zhong, Bang-Hua and Ma, Yu-Teng and Sun, Jian and Tang, Jing-Tong and Dong, Ming},
title = {Transcription factor FOXF2 promotes the development and progression of pancreatic cancer by targeting MSI2},
journal = {Oncology Reports},
year = {2024},
doi = {10.3892/or.2024.8752}
}
EUVIMED